Why Is Lyra Therapeutics (LYRA) Stock Down 90% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Lyra Therapeutics stock is falling hard with heavy trading on Monday after the company reported a failed Phase 3 clinical trial.

The post Why Is Lyra Therapeutics (LYRA) Stock Down 90% Today? appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”